Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “a Randomized Double-blind Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00873379
What this trial is testing

Melatonin Supplementation for Delirium Prevention in Acutely Hospitalized Elderly

Who this might be right for
Delirium
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 122
Post-approval studies (Phase 4)Study completedNCT00489255
What this trial is testing

Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment

Who this might be right for
Parkinson's Disease
Ipsen 117
Large-scale testing (Phase 3)Study completedNCT05583526
What this trial is testing

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

Who this might be right for
Stable Nonsegmental VitiligoActive Nonsegmental Vitiligo
Pfizer 607
Testing effectiveness (Phase 2)WithdrawnNCT02252978
What this trial is testing

Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences
Not applicableStudy completedNCT02797678
What this trial is testing

Feasibility, Effectiveness and Efficacy of the PowerSleep Device

Who this might be right for
SleepSleep Disorders Not Due to A Substance or Known Physiological Condition
Philips Respironics 62
Testing effectiveness (Phase 2)Ended earlyNCT01679678
What this trial is testing

A Study, Performed in Subjects With Post Traumatic-post Surgical ,Venus Insufficiency and Diabetic Hard to Heal/Chronic Wounds, to Evaluate the Safety and Efficacy of PolyHeal-2 Versus PolyHeal in Once Daily Regimen

Who this might be right for
Surgical Wound Dehiscence
MediWound Ltd 15
Post-approval studies (Phase 4)Not Yet RecruitingNCT07685743
What this trial is testing

Extended Post-operative Oral TXA in Primary THA

Who this might be right for
Osteoarthritis (OA) of the HipOsteoarthritis (OA) of the Knee
Oregon Health and Science University 170
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07754825
What this trial is testing

A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Shanghai Pharmaceuticals Holding Co., Ltd 300
Not applicableUnknownNCT06380725
What this trial is testing

The Treatment of High Intensity Transcranial Current Stimulation for Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentDementia
Anhui Provincial Hospital 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06291376
What this trial is testing

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A NephropathyIgAN
Alexion Pharmaceuticals, Inc. 579
Not applicableStudy completedNCT00830817
What this trial is testing

Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis

Who this might be right for
Psoriasis
Welichem Biotech Inc. 36
Large-scale testing (Phase 3)Ended earlyNCT03559517
What this trial is testing

Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)

Who this might be right for
Crohn's Disease
Shire 30
Testing effectiveness (Phase 2)Looking for participantsNCT06197568
What this trial is testing

Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women

Who this might be right for
Vulvo Vaginal Atrophy (VVA)
Azure Biotech Inc. 90
Large-scale testing (Phase 3)Ended earlyNCT03710291
What this trial is testing

Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis

Who this might be right for
Metabolic AcidosisChronic Kidney Disease
Tricida, Inc. 1,480
Testing effectiveness (Phase 2)Study completedNCT03061474
What this trial is testing

Nicotinamide as an Early Alzheimer's Disease Treatment

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
University of California, Irvine 46
Testing effectiveness (Phase 2)Study completedNCT00236613
What this trial is testing

A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

Who this might be right for
Obesity
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 385
Not applicableStudy completedNCT04540913
What this trial is testing

RHA® 3 Versus Restylane-L® for Lip Augmentation

Who this might be right for
Lip AugmentationLip
Teoxane SA 202
Large-scale testing (Phase 3)UnknownNCT02130882
What this trial is testing

Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome

Who this might be right for
Respiratory System AgentsAnti-Asthmatic AgentsHematologic Diseases+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04765059
What this trial is testing

Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 98
Testing effectiveness (Phase 2)Study completedNCT01097096
What this trial is testing

Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 177
Next Page